Jones, Yes I guess it depends what the 'fair' value is, revaluations will further eat into equity. Ratio's aren't looking good.Also just thinking laterally, if they didn't pay $5M due in April what chance do they have in May?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025